---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-004686"
form_type: "8-K/A"
ticker: "ULBI"
cik: "0000875657"
company_name: "ULTRALIFE CORP"
filed_at: "2022-02-28T23:59:59+00:00"
generated_at: "2026-06-27T03:56:59.767212+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ultralife files audited Excell financials: $18.5M sales, $1.5M net income for Feb-Dec 2021 stub

## Summary
- Sales $18.46M, gross profit $4.32M (23.4% margin), net income $1.49M for period Feb 1-Dec 12, 2021.
- Total assets $9.0M, equity $6.45M; cash $736K, accounts receivable $3.57M, inventory $3.44M.
- Auditor MNP LLP issued qualified opinion unable to audit opening inventory affecting cost of sales.
- Company paid $4.78M dividends and repaid $729K shareholder advances during stub period.
- Acquisition closed Dec 13, 2021; financials now filed via Form 8-K/A.

## SEC filing metadata
- accession: 0001437749-22-004686
- form_type: 8-K/A
- ticker: ULBI
- cik: 0000875657
- company_name: ULTRALIFE CORP
- filed_at: 2022-02-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/0001437749-22-004686-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875657/000143774922004686/ulbi20220228_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-004686
- JSON: https://secwatch.observer/filing/0001437749-22-004686.json
- Plain text: https://secwatch.observer/filing/0001437749-22-004686.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.